Cite
MLA Citation
Ajai Chari et al.. “Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma.” Leukemia & lymphoma, vol. 59, no. 11, 2018, pp. 2588–2594. http://access.bl.uk/ark:/81055/vdc_100075228343.0x000032